A range of funding is available, either managed by or provided by Imperial Innovations, to support Imperial academic staff in the development of their commercially promising technologies.
Apollo Therapeutics is a £40 million initiative providing translational funding for biomedical projects developed at Imperial College London, University College London and the University of Cambridge
Innovator Awards are open to researchers who are developing healthcare innovations that could have a major and measurable impact on human health. Up to £750,000 is available per project.
These Seed Awards help researchers to develop novel ideas that will go on to form part of larger grant applications to Wellcome or elsewhere. Up to £100,000 is available.
Baxter and MedCity are looking to partner with innovators interested in bringing their novel technology or innovate ideas to market.